“…Among the various types of nitrogen-containing heterocycles, derivatives of 3,4-dihydropyrimidin-2(1 H )-one, as biologically-active compounds, have found versatile applications such as anti-bacterial, anti-inflammatory, antihypertensive agents, calcium channel blockers and antitumor compounds. 52–60 A simple and general protocol for access to 3,4-dihydropyrimidin-2(1 H )-ones involves the three-component and one-pot Biginelli cyclocondensation of ethyl acetoacetate, urea and various aldehydes accelerated by different types of acidic catalytic systems such as copper( ii ) trifluoromethanesulfonate under microwave irradiation, 61 gallium( iii ) triflate, 62 bismuth pyromanganate nanoparticles, 63 l -proline methyl ester hydrochloride, 64 nanometasilica disulfuric acid, 65 p -toluenesulfonic acid, 66,67 sulfonic acid-supported polymeric catalysts, 68 sulfonated carbons from agro-industrial wastes, 69 phenylboronic acid, 70 1,3-bis(carboxymethyl)imidazolium chloride, 71 sulfonic acid and ionic liquid functionalized covalent organic frameworks, 72 ionic liquid combined with acidic zeolite-supported heteropolyacids, 73 ionic liquid/silica sulfuric acid, 74 bentonite/PS-SO 3 H nanocomposite, 75 dendrimer-attached phosphotungstic acid immobilized on nanosilica under ultrasonication, 76 tungsten-substituted molybdophosphoric acid impregnated with kaolin, 53 zinc- and cadmium-based coordination polymers, 77 metal–organic frameworks (MOFs), 78,79 montmorillonite clay, 80 magnetic nanoparticles, 81 Lewis acidic zirconium( iv )–salophen perfluorooctanesulfonate or sulfated polyborate, 82,83 nanocrystalline CdS thin film, 59 graphene oxide, 84,85 and mesoporous materials. 86,87 Most of the reported methods in this regard demonstrate valuable role of heterogeneous catalysts.…”